中南米の遺伝子発現市場2020-2027:市場規模、シェア、動向分析

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GV21JA065)
◆英語タイトル:Latin America Gene Expression Market Size, Share & Trends Analysis Report By Process, By Product (DNA Chips, Kits & Reagents), By Capacity, By Application, By Technique, By Region, And Segment Forecasts, 2020 - 2027
◆発行会社/調査会社:Grand View Research
◆商品コード:GV21JA065
◆発行日:2020年11月30日
◆調査対象地域:中南米
◆産業分野:バイオ
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Enterprise UserUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[中南米の遺伝子発現市場2020-2027:市場規模、シェア、動向分析]についてメールでお問い合わせはこちら
グランドビューリサーチ社は、遺伝子発現の中南米市場規模が2027年までに578.3百万ドルに達すると予測しています。2020年から2027年までに年平均5.6%成長する見通しです。本市場調査資料では、遺伝子発現の中南米市場を広く調査・分析し、エグゼクティブサマリー、研究手法、市場変動・動向・範囲、プロセス別分析、製品別分析、容量別分析、用途別分析、技術別分析、市域別分析、企業情報など、以下の構成でまとめております。
*** レポート概要(サマリー)***

Latin America Gene Expression Market Growth & Trends
The Latin America gene expression market size is expected to reach USD 578.3 million by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.6% from 2020 to 2027. High investment in alternative approaches for drug discovery and an increased number of projects involving genetic studies are expected to drive demand.

The region is characterized by fragmented healthcare and a high rate of poverty as well as disparities to access to standard care for cancer and other complex disorders. In this region, consumers from public settings are unable to afford targeted therapies. The number of facilities providing genomic platforms is limited in the region. These factors have resulted in the low revenue share of the Latin America market in the global market for gene expression.

However, researchers and healthcare providers are pursuing training for the use of genomic platforms and constantly participating in genomic projects. Currently, a medical practice based on precision medicine is still a challenge and limited to private settings in Latin America. A rise in the number of research studies pertaining to gene expression, genomic medicine, and personalized medicine in the LATAM region is expected to drive the market.

The Brazilian Initiative on Precision Medicine (BIPMed) is the first Latin American and Brazilian beacon, which is a genetic mutation sharing platform established by the Global Alliance for Genomics and Health (GA4GH). BIPMed encourages propagation and guidance in areas of computational ecology, personalized medicine, molecular hereditary, and others. This initiative plays an important role in the development of precision medicine in Latin America, thereby enabling significant advancements in healthcare and research in this region.

Latin America Gene Expression Market Report Highlights

• cDNA synthesis and conversion accounted for the largest revenue share in 2019. The introduction of systems that provide direct library synthesis eliminating the need for prior steps is expected to increase the revenue share of the segment

• Kits and reagents generated the largest product revenue in 2019 owing to the commercial availability of a broad range of kits and reagents to support biological discoveries and advancements

• Moreover, the introduction of enhanced kits and reagents that support better workflow, also contributes to segment growth

• Availability of products with higher efficiency, better adoption to specific research need, and decline in prices of associated techniques is projected to drive growth in the coming years

• High-Plex capacity is expected to witness the fastest CAGR from 2020 to 2027. The segment also accounted for the largest revenue share owing to high adoption in clinical and drug discovery uses

• Increased demand for advanced diagnostic solutions is expected to fuel the growth of the clinical diagnostics segment

• RNA expression dominated the technique segment. Technological advances in RNA expression tools and techniques coupled with the availability of a range of products to meet different research needs are anticipated to increase the adoption of these techniques for gene expression analysis

• Brazil accounted for the largest revenue generation in 2019 owing to continuous developments in genomic and healthcare-related research in the country

• Competition in the market is high due to the presence of a substantial number of well-established companies and small- to mid-sized entities

• Key players are manufacturing and commercializing products to cater to various requirements in gene expression. To maintain a significant share in the market, players have implemented several business strategies including the expansion of distribution network, product portfolio, and increase in manufacturing capacity through mergers and collaborations

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Executive Summary
1.1 Market Outlook
1.2 Market Segmentation
1.3 Competition Milieu
1.4 Market Summary
Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Information or Data Analysis
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related Market Outlook
3.2 Market Dynamics
3.2.1 Market Drivers Analysis
3.2.1.1 Declining price of sequencing
3.2.1.2 Technological advancements in gene expression analysis
3.2.1.3 Rising investment in genomic research
3.2.1.4 Increase in cancer incidence
3.2.1.5 Increased focus on precision medicine
3.2.2 Market restraint Analysis
3.2.2.1 High price of instruments
3.2.2.2 Challenges in data analysis
3.3 Major Deals & Strategic Alliances Analysis
3.3.1 Mergers & acquisitions
3.3.2 Partnerships & collaborations
3.3.3 Agreement
3.4 Market Entry Strategies
3.5 Penetration & Growth Prospect Mapping for Process, 2019
3.6 SWOT analysis, by factor (Political & legal, economic, and technological)
3.7 Porter’s Five Forces Analysis
Chapter 4 Process Business Analysis
4.1 Latin America Gene Expression Market: Process Movement Analysis
4.2 Sample Collection
4.2.1 Latin America gene expression market for sample collection process, 2016 – 2027 (USD Million)
4.3 Purification
4.3.1 Latin America gene expression market for purification process, 2016 – 2027 (USD Million)
4.4 cDNA Synthesis & Conversion
4.4.1 Latin America gene expression market for cDNA synthesis & conversion process, 2016 – 2027 (USD Million)
4.5 PCR Analysis
4.5.1 Latin America gene expression market for PCR analysis, 2016 – 2027 (USD Million)
4.6 Data Analysis & Interpretation
4.6.1 Latin America gene expression market for data analysis & interpretation process, 2016 – 2027 (USD Million)
Chapter 5 Product Business Analysis
5.1 Latin America Gene Expression Market: Product Movement Analysis
5.2 Kits & Reagents
5.2.1 Latin America kits & reagents market for gene expression, 2016 – 2027 (USD Million)
5.3 DNA Chips
5.3.1 Latin America DNA chips market for gene expression, 2016 – 2027 (USD Million)
5.4 Other Products
5.4.1 Latin America other product market for gene expression, 2016 – 2027 (USD Million)
Chapter 6 Capacity Business Analysis
6.1 Latin America Gene Expression Market: Capacity Movement Analysis
6.2 Low – to Mid – Plex
6.2.1 Latin America Low – to Mid – Plex gene expression Market, 2016 – 2027 (USD Million)
6.3 High – Plex
6.3.1 Latin America high – Plex gene expression Market, 2016 – 2027 (USD Million)
Chapter 7 Application Business Analysis
7.1 Latin America Gene Expression Market: Application Movement Analysis
7.2 Drug Discovery & Development
7.2.1 Latin America drug discovery & development – based gene expression Market, 2016 – 2027 (USD Million)
7.3 Clinical Diagnostics
7.3.1 Latin America clinical diagnostics – based gene expression Market, 2016 – 2027 (USD Million)
7.4 Biotech & Microbiology
7.4.1 Latin America biotech & microbiology – based gene expression Market, 2016 – 2027 (USD Million)
7.5 Other Applications
7.5.1 Latin America other applications – based gene expression Market, 2016 – 2027 (USD Million)
Chapter 8 Technique Business Analysis
8.1 Latin America Gene Expression Market: Technique Movement Analysis, 2019 & 2027
8.2 RNA Expression
8.2.1 Latin America RNA expression – based gene expression Market, 2016 – 2027 (USD Million)
8.2.2 Northern blotting
8.2.2.1 Latin America northern blotting – based RNA expression Market, 2016 – 2027 (USD Million)
8.2.3 DNA microarrays
8.2.3.1 Latin America DNA microarrays – based RNA expression Market, 2016 – 2027 (USD Million)
8.2.4 PCR techniques
8.2.4.1 Latin America PCR techniques – based RNA expression Market, 2016 – 2027 (USD Million)
8.2.5 RNA sequencing
8.2.5.1 Latin America RNA sequencing – based RNA expression Market, 2016 – 2027 (USD Million)
8.3 Promoter Analysis
8.3.1 Latin America promoter analysis – based gene expression Market, 2016 – 2027 (USD Million)
8.3.2 In vitro transcription/nuclear run – on assays market
8.3.2.1 Latin America in vitro transcription/nuclear run – on assays Market, 2016 – 2027 (USD Million)
8.3.3 Gel shift assays
8.3.3.1 Latin America gel shift assays Market, 2016 – 2027 (USD Million)
8.3.4 Chromatin Immunoprecipitation (ChIP)
8.3.4.1 Latin America Chromatin Immunoprecipitation (ChIP) Market, 2016 – 2027 (USD Million)
8.4 Protein Expression & Post – translational Modification Analysis
8.4.1 Latin America protein expression & post – translational modification analysis – based gene expression Market, 2016 – 2027 (USD Million)
8.4.2 Western blotting
8.4.2.1 Latin America western blotting – based market, 2016 – 2027 (USD Million)
8.4.3 2 – D gel electrophoresis
8.4.3.1 Latin America 2 – D gel electrophoresis – based market, 2016 – 2027 (USD Million)
8.4.4 Immunoassays
8.4.4.1 Latin America immunoassays – based market, 2016 – 2027 (USD Million)
8.4.5 Mass spectroscopy
8.4.5.1 Latin America mass spectrometry – based market, 2016 – 2027 (USD Million)
Chapter 9 Regional Business Analysis
9.1 Latin America Gene Expression Market: Regional Movement Analysis
9.2 Latin America
9.2.1 Latin America gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.2 Brazil
9.2.2.1 Brazil gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.2.2 Brazil gene expression market, by process, 2016 – 2027 (USD Million)
9.2.2.3 Brazil gene expression market, by product, 2016 – 2027 (USD Million)
9.2.2.4 Brazil gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.2.5 Brazil gene expression market, by application, 2016 – 2027 (USD Million)
9.2.2.6 Brazil gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.3 Mexico
9.2.3.1 Mexico gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.3.2 Mexico gene expression market, by process, 2016 – 2027 (USD Million)
9.2.3.3 Mexico gene expression market, by product, 2016 – 2027 (USD Million)
9.2.3.4 Mexico gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.3.5 Mexico gene expression market, by application, 2016 – 2027 (USD Million)
9.2.3.6 Mexico gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.4 Argentina
9.2.4.1 Argentina gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.4.2 Argentina gene expression market, by process, 2016 – 2027 (USD Million)
9.2.4.3 Argentina gene expression market, by product, 2016 – 2027 (USD Million)
9.2.4.4 Argentina gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.4.5 Argentina gene expression market, by application, 2016 – 2027 (USD Million)
9.2.4.6 Argentina gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.5 Colombia
9.2.5.1 Colombia gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.5.2 Colombia gene expression market, by process, 2016 – 2027 (USD Million)
9.2.5.3 Colombia gene expression market, by product, 2016 – 2027 (USD Million)
9.2.5.4 Colombia gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.5.5 Colombia gene expression market, by application, 2016 – 2027 (USD Million)
9.2.5.6 Colombia gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.6 Chile
9.2.6.1 Chile gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.6.2 Chile gene expression market, by process, 2016 – 2027 (USD Million)
9.2.6.3 Chile gene expression market, by product, 2016 – 2027 (USD Million)
9.2.6.4 Chile gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.6.5 Chile gene expression market, by application, 2016 – 2027 (USD Million)
9.2.6.6 Chile gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.7 Peru
9.2.7.1 Peru gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.7.2 Peru gene expression market, by process, 2016 – 2027 (USD Million)
9.2.7.3 Peru gene expression market, by product, 2016 – 2027 (USD Million)
9.2.7.4 Peru gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.7.5 Peru gene expression market, by application, 2016 – 2027 (USD Million)
9.2.7.6 Peru gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.8 Ecuador
9.2.8.1 Ecuador gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.8.2 Ecuador gene expression market, by process, 2016 – 2027 (USD Million)
9.2.8.3 Ecuador gene expression market, by product, 2016 – 2027 (USD Million)
9.2.8.4 Ecuador gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.8.5 Ecuador gene expression market, by application, 2016 – 2027 (USD Million)
9.2.8.6 Ecuador gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.9 Dominican Republic (República Dominicana)
9.2.9.1 Dominican Republic (República Dominicana) gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.9.2 Dominican Republic gene expression market, by process, 2016 – 2027 (USD Million)
9.2.9.3 Dominican Republic gene expression market, by product, 2016 – 2027 (USD Million)
9.2.9.4 Dominican Republic gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.9.5 Dominican Republic gene expression market, by application, 2016 – 2027 (USD Million)
9.2.9.6 Dominican Republic gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.10 Venezuela
9.2.10.1 Venezuela gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.10.2 Venezuela gene expression market, by process, 2016 – 2027 (USD Million)
9.2.10.3 Venezuela gene expression market, by product, 2016 – 2027 (USD Million)
9.2.10.4 Venezuela gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.10.5 Venezuela gene expression market, by application, 2016 – 2027 (USD Million)
9.2.10.6 Venezuela gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.11 Guatemala
9.2.11.1 Guatemala gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.11.2 Guatemala gene expression market, by process, 2016 – 2027 (USD Million)
9.2.11.3 Guatemala gene expression market, by product, 2016 – 2027 (USD Million)
9.2.11.4 Guatemala gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.11.5 Guatemala gene expression market, by application, 2016 – 2027 (USD Million)
9.2.11.6 Guatemala gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.12 Panama
9.2.12.1 Panama gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.12.2 Panama gene expression market, by process, 2016 – 2027 (USD Million)
9.2.12.3 Panama gene expression market, by product, 2016 – 2027 (USD Million)
9.2.12.4 Panama gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.12.5 Panama gene expression market, by application, 2016 – 2027 (USD Million)
9.2.12.6 Panama gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.13 Costa Rica
9.2.13.1 Costa Rica gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.13.2 Cost Rica gene expression market, by process, 2016 – 2027 (USD Million)
9.2.13.3 Cost Rica gene expression market, by product, 2016 – 2027 (USD Million)
9.2.13.4 Cost Rica gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.13.5 Cost Rica gene expression market, by application, 2016 – 2027 (USD Million)
9.2.13.6 Cost Rica gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.14 Uruguay
9.2.14.1 Uruguay gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.14.2 Uruguay gene expression market, by process, 2016 – 2027 (USD Million)
9.2.14.3 Uruguay gene expression market, by product, 2016 – 2027 (USD Million)
9.2.14.4 Uruguay gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.14.5 Uruguay gene expression market, by application, 2016 – 2027 (USD Million)
9.2.14.6 Uruguay gene expression market, by technique, 2016 – 2027 (USD Million)
9.2.15 Cuba
9.2.15.1 Cuba gene expression market estimates and forecast, 2016 – 2027 (USD Million)
9.2.15.2 Cuba gene expression market, by process, 2016 – 2027 (USD Million)
9.2.15.3 Cuba gene expression market, by product, 2016 – 2027 (USD Million)
9.2.15.4 Cuba gene expression market, by capacity, 2016 – 2027 (USD Million)
9.2.15.5 Cuba gene expression market, by application, 2016 – 2027 (USD Million)
9.2.15.6 Cuba gene expression market, by technique, 2016 – 2027 (USD Million)
Chapter 10 Company Profiles
10.1 Company Profiles
10.1.1 Illumina, Inc.
10.1.1.1 Company overview
10.1.1.2 Financial Performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 F. Hoffmann – La Roche Ltd.
10.1.2.1 Company overview
10.1.2.2 Financial Performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 Agilent Technologies, Inc.
10.1.3.1 Company overview
10.1.3.2 Financial Performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 Thermo Fisher Scientific, Inc.
10.1.4.1 Company overview
10.1.4.2 Life Technologies Corp.
10.1.4.2.1 Company overview
10.1.4.3 Affymetrix, Inc.
10.1.4.4 Financial Performance
10.1.4.5 Product benchmarking
10.1.4.6 Strategic initiatives (Beckman Coulter)
10.1.5 Bio – Rad Laboratories, Inc.
10.1.5.1 Company overview
10.1.5.2 Financial Performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 Novogene Co., Ltd.
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 Danaher
10.1.7.1 Company overview
10.1.7.2 Integrated DNA Technologies, Inc.
10.1.7.2.1 Company overview
10.1.7.3 Financial Performance
10.1.7.3.1 Financial performance (Integrated DNA Technologies, Inc.)
10.1.7.4 Product benchmarking
10.1.7.5 Strategic initiatives
10.1.8 Sysmex Corporation
10.1.8.1 Company overview
10.1.8.2 Oxford Gene Technology
10.1.8.2.1 Company overview
10.1.8.3 Financial Performance
10.1.8.3.1 Financial performance (Oxford Gene Technology.)
10.1.8.4 Product benchmarking
10.1.8.5 Strategic initiatives
10.1.9 Idengene SA
10.1.9.1 Company overview
10.1.9.2 Product benchmarking
10.1.9.3 Strategic initiatives
10.1.10 ONKOS Diagnósticos Moleculares LTDA
10.1.10.1 Company overview
10.1.10.2 Product benchmarking

List of Tables

Table 1 Incidence and mortality rate of cancer in Latin America and the Caribbean in 2018
Table 2 Comparison of gene expression platforms
Table 3 Immunoassays for protein expression analysis with detection labels
Table 4 Standard materials for immune assays
Table 5 Brazil gene expression market, by process, 2016 - 2027 (USD Million)
Table 6 Brazil gene expression market, by product, 2016 - 2027 (USD Million)
Table 7 Brazil gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 8 Brazil gene expression market, by application, 2016 - 2027 (USD Million)
Table 9 Brazil gene expression market, by technique, 2016 - 2027 (USD Million)
Table 10 Brazil RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 11 Brazil promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 12 Brazil PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 13 Mexico gene expression market, by process, 2016 - 2027 (USD Million)
Table 14 Mexico gene expression market, by product, 2016 - 2027 (USD Million)
Table 15 Mexico gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 16 Mexico gene expression market, by application, 2016 - 2027 (USD Million)
Table 17 Mexico gene expression market, by technique, 2016 - 2027 (USD Million)
Table 18 Mexico RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 19 Mexico promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 20 Mexico PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 21 Argentina gene expression market, by process, 2016 - 2027 (USD Million)
Table 22 Argentina gene expression market, by product, 2016 - 2027 (USD Million)
Table 23 Argentina gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 24 Argentina gene expression market, by application, 2016 - 2027 (USD Million)
Table 25 Argentina gene expression market, by technique, 2016 - 2027 (USD Million)
Table 26 Argentina RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 27 Argentina promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 28 Argentina PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 29 Colombia gene expression market, by process, 2016 - 2027 (USD Million)
Table 30 Colombia gene expression market, by product, 2016 - 2027 (USD Million)
Table 31 Colombia gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 32 Colombia gene expression market, by application, 2016 - 2027 (USD Million)
Table 33 Colombia gene expression market, by technique, 2016 - 2027 (USD Million)
Table 34 Colombia RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 35 Colombia promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 36 Colombia PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 37 Chile gene expression market, by process, 2016 - 2027 (USD Million)
Table 38 Chile gene expression market, by product, 2016 - 2027 (USD Million)
Table 39 Chile gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 40 Chile gene expression market, by application, 2016 - 2027 (USD Million)
Table 41 Chile gene expression market, by technique, 2016 - 2027 (USD Million)
Table 42 Chile RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 43 Chile promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 44 Chile PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 45 Peru gene expression market, by process, 2016 - 2027 (USD Million)
Table 46 Peru gene expression market, by product, 2016 - 2027 (USD Million)
Table 47 Peru gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 48 Peru gene expression market, by application, 2016 - 2027 (USD Million)
Table 49 Peru gene expression market, by technique, 2016 - 2027 (USD Million)
Table 50 Peru RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 51 Peru promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 52 Peru PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 53 Ecuador gene expression market, by process, 2016 - 2027 (USD Million)
Table 54 Ecuador gene expression market, by product, 2016 - 2027 (USD Million)
Table 55 Ecuador gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 56 Ecuador gene expression market, by application, 2016 - 2027 (USD Million)
Table 57 Ecuador gene expression market, by technique, 2016 - 2027 (USD Million)
Table 58 Ecuador RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 59 Ecuador promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 60 Ecuador PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 61 Dominican Republic gene expression market, by process, 2016 - 2027 (USD Million)
Table 62 Dominican Republic gene expression market, by product, 2016 - 2027 (USD Million)
Table 63 Dominican Republic gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 64 Dominican Republic gene expression market, by application, 2016 - 2027 (USD Million)
Table 65 Dominican Republic gene expression market, by technique, 2016 - 2027 (USD Million)
Table 66 Dominican Republic RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 67 Dominican Republic promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 68 Dominican Republic PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 69 Venezuela gene expression market, by process, 2016 - 2027 (USD Million)
Table 70 Venezuela gene expression market, by product, 2016 - 2027 (USD Million)
Table 71 Venezuela gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 72 Venezuela gene expression market, by application, 2016 - 2027 (USD Million)
Table 73 Venezuela gene expression market, by technique, 2016 - 2027 (USD Million)
Table 74 Venezuela RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 75 Venezuela promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 76 Venezuela PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 77 Guatemala gene expression market, by process, 2016 - 2027 (USD Million)
Table 78 Guatemala gene expression market, by product, 2016 - 2027 (USD Million)
Table 79 Guatemala gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 80 Guatemala gene expression market, by application, 2016 - 2027 (USD Million)
Table 81 Guatemala gene expression market, by technique, 2016 - 2027 (USD Million)
Table 82 Guatemala RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 83 Guatemala promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 84 Guatemala PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 85 Panama gene expression market, by process, 2016 - 2027 (USD Million)
Table 86 Panama gene expression market, by product, 2016 - 2027 (USD Million)
Table 87 Panama gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 88 Panama gene expression market, by application, 2016 - 2027 (USD Million)
Table 89 Panama gene expression market, by technique, 2016 - 2027 (USD Million)
Table 90 Panama RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 91 Panama promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 92 Panama PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 93 Cost Rica gene expression market, by process, 2016 - 2027 (USD Million)
Table 94 Cost Rica gene expression market, by product, 2016 - 2027 (USD Million)
Table 95 Cost Rica gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 96 Cost Rica gene expression market, by application, 2016 - 2027 (USD Million)
Table 97 Cost Rica gene expression market, by technique, 2016 - 2027 (USD Million)
Table 98 Cost Rica RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 99 Cost Rica promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 100 Cost Rica PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 101 Uruguay gene expression market, by process, 2016 - 2027 (USD Million)
Table 102 Uruguay gene expression market, by product, 2016 - 2027 (USD Million)
Table 103 Uruguay gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 104 Uruguay gene expression market, by application, 2016 - 2027 (USD Million)
Table 105 Uruguay gene expression market, by technique, 2016 - 2027 (USD Million)
Table 106 Uruguay RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 107 Uruguay promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 108 Uruguay PE & PMA market, by technique, 2016 - 2027 (USD Million)
Table 109 Cuba gene expression market, by process, 2016 - 2027 (USD Million)
Table 110 Cuba gene expression market, by product, 2016 - 2027 (USD Million)
Table 111 Cuba gene expression market, by capacity, 2016 - 2027 (USD Million)
Table 112 Cuba gene expression market, by application, 2016 - 2027 (USD Million)
Table 113 Cuba gene expression market, by technique, 2016 - 2027 (USD Million)
Table 114 Cuba RNA expression market, by technique, 2016 - 2027 (USD Million)
Table 115 Cuba promoter analysis market, by technique, 2016 - 2027 (USD Million)
Table 116 Cuba PE & PMA market, by technique, 2016 - 2027 (USD Million)


List of Figures

Fig. 1 Market segmentation & scope
Fig. 2 Latin America gene expression market snapshot, USD Million, 2019
Fig. 3 Market research process
Fig. 4 Information procurement
Fig. 5 Industry pyramid analysis
Fig. 6 Industry pyramid analysis
Fig. 7 Market research approaches
Fig. 8 Value - chain - based sizing & forecasting
Fig. 9 Industry pyramid analysis
Fig. 10 Industry pyramid analysis
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 DNA sequencing cost per genome
Fig. 13 Illumina’s sequencing cost per MB
Fig. 14 Estimates of Research, Condition, and Disease Categories (RCDC) funding for cancer genomics
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Penetration & growth prospect mapping, by process, 2019
Fig. 17 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 18 Porter’s Five Forces Analysis
Fig. 19 Latin America gene expression market: Process outlook and key takeaways
Fig. 20 Latin America gene expression market: Process movement analysis (USD Million)
Fig. 21 Latin America gene expression market for sample collection process, 2016 - 2027 (USD Million)
Fig. 22 Latin America gene expression market for purification process, 2016 - 2027 (USD Million)
Fig. 23 Latin America gene expression market for cDNA synthesis & conversion process, 2016 - 2027 (USD Million)
Fig. 24 Latin America gene expression market for PCR analysis, 2016 - 2027 (USD Million)
Fig. 25 Latin America gene expression market for data analysis & interpretation process, 2016 - 2027 (USD Million)
Fig. 26 Latin America gene expression market: Product outlook and key takeaways
Fig. 27 Latin America gene expression market: Product movement analysis (USD Million)
Fig. 28 Latin America kits & reagents market for gene expression, 2016 - 2027 (USD Million)
Fig. 29 Latin America DNA chips market for gene expression, 2016 - 2027 (USD Million)
Fig. 30 Latin America other product market for gene expression, 2016 - 2027 (USD Million)
Fig. 31 Latin America gene expression market: Capacity outlook and key takeaways
Fig. 32 Latin America gene expression market: Capacity movement analysis (USD Million)
Fig. 33 Latin America low - to mid - plex gene expression Market, 2016 - 2027 (USD Million)
Fig. 34 Latin America high - plex gene expression Market, 2016 - 2027 (USD Million)
Fig. 35 Latin America gene expression market: Application outlook and key takeaways
Fig. 36 Latin America gene expression market: Application movement analysis (USD Million)
Fig. 37 Latin America drug discovery & development - based gene expression market, 2016 - 2027 (USD Million)
Fig. 38 Latin America clinical diagnostics - based gene expression market, 2016 - 2027 (USD Million)
Fig. 39 Latin America biotech & microbiology - based gene expression market, 2016 - 2027 (USD Million)
Fig. 40 Latin America other applications - based gene expression market, 2016 - 2027 (USD Million)
Fig. 41 Latin America gene expression market: Technique outlook and key takeaways
Fig. 42 Latin America gene expression market: Technique movement analysis (USD Million)
Fig. 43 Latin America RNA expression-based gene expression market, 2016 - 2027 (USD Million)
Fig. 44 Latin America Northern blotting - based RNA expression market, 2016 - 2027 (USD Million)
Fig. 45 Latin America DNA microarrays - based RNA expression market, 2016 - 2027 (USD Million)
Fig. 46 Latin America PCR techniques - based RNA expression market, 2016 - 2027 (USD Million)
Fig. 47 Latin America RNA sequencing-based RNA expression market, 2016 - 2027 (USD Million)
Fig. 48 Latin America promoter analysis - based gene expression market, 2016 - 2027 (USD Million)
Fig. 49 Latin America in vitro transcription/nuclear run-on assays market, 2016 - 2027 (USD Million)
Fig. 50 Latin America gel shift assays market, 2016 - 2027 (USD Million)
Fig. 51 Latin America Chromatin Immunoprecipitation (ChIP) market, 2016 - 2027 (USD Million)
Fig. 52 Latin America protein expression & post-translational modification analysis - based gene expression market, 2016 - 2027 (USD Million)
Fig. 53 Latin America western blotting - based market, 2016 - 2027 (USD Million)
Fig. 54 Latin America 2 - D gel electrophoresis - based market, 2016 - 2027 (USD Million)
Fig. 55 Latin America immunoassays - based market, 2016 - 2027 (USD Million)
Fig. 56 Latin America mass spectrometry-based market, 2016 - 2027 (USD Million)
Fig. 57 Latin America gene expression market: Regional movement analysis
Fig. 58 Latin America gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 59 Brazil gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 60 Mexico gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 61 Argentina gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 62 Colombia gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 63 Chile gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 64 Peru gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 65 Ecuador gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 66 Dominican Republic (República Dominicana) gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 67 Venezuela gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 68 Guatemala gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 69 Panama gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 70 Costa Rica gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 71 Uruguay gene expression market estimates and forecast, 2016 - 2027 (USD Million)
Fig. 72 Cuba gene expression market estimates and forecast, 2016 - 2027 (USD Million)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GV21JA065 )"中南米の遺伝子発現市場2020-2027:市場規模、シェア、動向分析" (英文:Latin America Gene Expression Market Size, Share & Trends Analysis Report By Process, By Product (DNA Chips, Kits & Reagents), By Capacity, By Application, By Technique, By Region, And Segment Forecasts, 2020 - 2027)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。